TRIM33 and cancer: Additionally, Pommier et al. reported that low TRIM33 expression is associated with increased genomic instability and subsequent cancer progression across multiple cancer types, including breast, pancreatic adenocarcinomas and clear cell renal cell carcinoma [33].